Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer

Published:2021-10 Issue:S1 Volume:128 Page:18-26
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Kelly Richard¹,Anton Angelyn¹²³^ORCID,Wong Shirley⁴,Shapiro Julia⁵,Weickhardt Andrew⁶,Azad Arun³⁷^ORCID,Kwan Edmond Michael³⁸,Spain Lavinia²³,Muthusamy Arun⁶,Torres Javier⁹,Parente Phillip²³,Parnis Francis¹⁰¹¹,Goh Jeffrey¹²,Joshua Anthony¹³,Pook David³⁷,Baenziger Olivia¹,Gibbs Peter¹⁴,Tran Ben¹⁷

Affiliation:

1. Walter and Eliza Hall Institute MelbourneVic.Australia

2. Eastern Health MelbourneVic.Australia

3. Monash University MelbourneVic.Australia

4. Western Health MelbourneVic.Australia

5. Alfred Health MelbourneVic.Australia

6. Olivia Newton‐John Cancer Wellness and Research Centre MelbourneVic.Australia

7. Peter MacCallum Cancer Centre MelbourneVic.Australia

8. Monash Health MelbourneVic.Australia

9. Goulburn Valley Health Shepparton Vic.Australia

10. Adelaide Cancer Centre AdelaideSAAustralia

11. University of Adelaide Adelaide SAAustralia